Yes you are right about the wounds business, but I believe that it is a formalisation of a collobaration with RAH which will be moved into a separate company but not necessarily an IPO. To give it some autonomy to advance the research.
XBL since the AGM preso has talked about IPO's to realise value. Poly Novo obvious chioice, while trade sale for Boron is a possibility.
Selling drying up.
- Forums
- ASX - By Stock
- XBL
- what the..? 250,000 buy just went through!!!
XBL
xceed biotechnology ltd
what the..? 250,000 buy just went through!!!, page-6
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)